Agency / Source: Greenphire, LLC

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Greenphire Receives EU-US Privacy Shield Certification - Achievement supports company’s commitment to data privacy, security and compliance - Greenphire.com
Greenphire Receives EU-US Privacy Shield Certification

 

PRZOOM - /newswire/ - King of Prussia, PA, United States, 2016/10/27 - Achievement supports company’s commitment to data privacy, security and compliance - Greenphire.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Greenphire, the global leader in clinical payment solutions, announced today that it has been certified by the U.S. Department of Commerce to the new EU-U.S. Privacy Shield Framework. The new framework requires companies to meet stronger obligations to protect the personal data of Europeans, and replaces the EU-U.S. Safe Harbor, with which Greenphire was already compliant.

“Our business sits at a crossroads of clinical trials and financial services two highly sensitive, highly regulated industries that rely on data privacy and compliance,” said Jim Murphy, CEO of Greenphire. “This certification demonstrates our commitment to data security and quality, providing just one more reason for sponsors, sites and patients to trust Greenphire.”

The EU-U.S. Privacy Shield Framework replaces the longstanding International Safe Harbor Privacy Principles. The U.S. Department of Commerce and European Commission developed the framework to allow organizations to comply with EU data protection requirements when transferring personal data from the European Union to the United States. Certification requirements include: greater transparency, oversight mechanisms to ensure companies abide by the rules, and tightened conditions for onward transfers.

Greenphire leads the industry in innovating and optimizing global clinical trial payments. Providing a better way to pay patients and sites around the world, Greenphire is the partner of choice to more than 500 clients, including 9 of the top 10 pharmaceutical companies.

About Greenphire

Greenphire (greenphire.com) is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Greenphire, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Greenphire Receives EU-US Privacy Shield Certification

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Greenphire | EU-US Privacy Shield Cert
Contact: Press Office - Greenphire.com 
215-609-4378 / 215-609-4640 corporate[.]greenphire.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Greenphire, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Greenphire, LLC / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Ono Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures
Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models through Automation
ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition
SCHOTT Pharma, Takeda and Corplex Bring Closed-loop Recycling System for Pharmaceutical Vial Trays into Operations
Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
STEMCELL Technologies Joins BLOODPAC to Advance Pre-Analytical Best Practices for Liquid Biopsy
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer
Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  JobsWare.com

Visit BizJobs.com

Visit  RightITnow, Inc.







 
  ©2005-2026 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS | 
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today